Recently, the osteoprotegerin (OPG), its binding protein–the receptor activator of NF-κB (RANK) and RANK ligand (RANKL) have been implicated with the pathogenesis of breast cancer [10]. This evidence concerns the gene TNFRSF11A and breast cancer.